Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 8,959 | 10,417 | 12,841 | 13,978 | 13,004 |
| Gross Profit | 8,959 | 10,417 | 12,841 | 13,978 | 13,004 |
| Operating Expenses | 18,465 | 17,463 | 15,940 | 15,067 | 13,569 |
| Operating Income | -9,506 | -7,046 | -3,099 | -1,089 | -565 |
| Interest Expense | 0 | 12 | 0 | 11 | 11 |
| Other Income | 549 | 536 | 471 | 458 | 483 |
| Pre-tax Income | -8,957 | -6,522 | -2,628 | -642 | -93 |
| Income Tax | -3,565 | -1,542 | -826 | 434 | 1,552 |
| Net Income Continuous | -5,392 | -4,980 | -1,802 | -1,076 | -1,645 |
| Net Income | $-5,392 | $-4,980 | $-1,802 | $-1,076 | $-1,645 |
| EPS Basic Total Ops | -0.28 | -0.26 | -0.10 | -0.06 | -0.09 |
| EPS Basic Continuous Ops | -0.28 | -0.26 | -0.11 | -0.06 | -0.09 |
| EPS Diluted Total Ops | -0.28 | -0.26 | -0.08 | -0.06 | -0.09 |
| EPS Diluted Continuous Ops | -0.28 | -0.26 | -0.09 | -0.06 | -0.09 |
| EBITDA(a) | $-8,760 | $-6,365 | $-2,437 | $-361 | $316 |